UniProt ID | NPHP4_HUMAN | |
---|---|---|
UniProt AC | O75161 | |
Protein Name | Nephrocystin-4 | |
Gene Name | NPHP4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1426 | |
Subcellular Localization | Cytoplasm, cytoskeleton, cilium basal body . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cell junction, tight junction . Nucleus . In cultured renal cells, it localizes diffusely in the cytoplasm but, as cells approach conflue | |
Protein Description | Involved in the organization of apical junctions; the function is proposed to implicate a NPHP1-4-8 module. [PubMed: 19755384] | |
Protein Sequence | MNDWHRIFTQNVLVPPHPQRARQPWKESTAFQCVLKWLDGPVIRQGVLEVLSEVECHLRVSFFDVTYRHFFGRTWKTTVKPTKRPPSRIVFNEPLYFHTSLNHPHIVAVVEVVAEGKKRDGSLQTLSCGFGILRIFSNQPDSPISASQDKRLRLYHGTPRALLHPLLQDPAEQNRHMTLIENCSLQYTLKPHPALEPAFHLLPENLLVSGLQQIPGLLPAHGESGDALRKPRLQKPITGHLDDLFFTLYPSLEKFEEELLELHVQDHFQEGCGPLDGGALEILERRLRVGVHNGLGFVQRPQVVVLVPEMDVALTRSASFSRKVVSSSKTSSGSQALVLRSRLRLPEMVGHPAFAVIFQLEYVFSSPAGVDGNAASVTSLSNLACMHMVRWAVWNPLLEADSGRVTLPLQGGIQPNPSHCLVYKVPSASMSSEEVKQVESGTLRFQFSLGSEEHLDAPTEPVSGPKVERRPSRKPPTSPSSPPAPVPRVLAAPQNSPVGPGLSISQLAASPRSPTQHCLARPTSQLPHGSQASPAQAQEFPLEAGISHLEADLSQTSLVLETSIAEQLQELPFTPLHAPIVVGTQTRSSAGQPSRASMVLLQSSGFPEILDANKQPAEAVSATEPVTFNPQKEESDCLQSNEMVLQFLAFSRVAQDCRGTSWPKTVYFTFQFYRFPPATTPRLQLVQLDEAGQPSSGALTHILVPVSRDGTFDAGSPGFQLRYMVGPGFLKPGERRCFARYLAVQTLQIDVWDGDSLLLIGSAAVQMKHLLRQGRPAVQASHELEVVATEYEQDNMVVSGDMLGFGRVKPIGVHSVVKGRLHLTLANVGHPCEQKVRGCSTLPPSRSRVISNDGASRFSGGSLLTTGSSRRKHVVQAQKLADVDSELAAMLLTHARQGKGPQDVSRESDATRRRKLERMRSVRLQEAGGDLGRRGTSVLAQQSVRTQHLRDLQVIAAYRERTKAESIASLLSLAITTEHTLHATLGVAEFFEFVLKNPHNTQHTVTVEIDNPELSVIVDSQEWRDFKGAAGLHTPVEEDMFHLRGSLAPQLYLRPHETAHVPFKFQSFSAGQLAMVQASPGLSNEKGMDAVSPWKSSAVPTKHAKVLFRASGGKPIAVLCLTVELQPHVVDQVFRFYHPELSFLKKAIRLPPWHTFPGAPVGMLGEDPPVHVRCSDPNVICETQNVGPGEPRDIFLKVASGPSPEIKDFFVIIYSDRWLATPTQTWQVYLHSLQRVDVSCVAGQLTRLSLVLRGTQTVRKVRAFTSHPQELKTDPKGVFVLPPRGVQDLHVGVRPLRAGSRFVHLNLVDVDCHQLVASWLVCLCCRQPLISKAFEIMLAAGEGKGVNKRITYTNPYPSRRTFHLHSDHPELLRFREDSFQVGGGETYTIGLQFAPSQRVGEEEILIYINDHEDKNEEAFCVKVIYQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
137 | Phosphorylation | FGILRIFSNQPDSPI CEEEEECCCCCCCCC | 31.98 | 30266825 | |
142 | Phosphorylation | IFSNQPDSPISASQD ECCCCCCCCCCCCCC | 30.71 | 30266825 | |
145 | Phosphorylation | NQPDSPISASQDKRL CCCCCCCCCCCCCCH | 25.83 | 26657352 | |
147 | Phosphorylation | PDSPISASQDKRLRL CCCCCCCCCCCCHHH | 31.92 | 29255136 | |
150 | Ubiquitination | PISASQDKRLRLYHG CCCCCCCCCHHHHCC | 45.77 | 21906983 | |
235 | Ubiquitination | LRKPRLQKPITGHLD CCCCCCCCCCCCCHH | 42.87 | - | |
315 | Phosphorylation | PEMDVALTRSASFSR CCCCEEECCCCCCEE | 16.91 | - | |
319 | Phosphorylation | VALTRSASFSRKVVS EEECCCCCCEEEEEC | 25.63 | 17081983 | |
321 | Phosphorylation | LTRSASFSRKVVSSS ECCCCCCEEEEECCC | 28.79 | - | |
329 | Ubiquitination | RKVVSSSKTSSGSQA EEEECCCCCCCCCHH | 55.14 | 2190698 | |
331 | Phosphorylation | VVSSSKTSSGSQALV EECCCCCCCCCHHHH | 36.12 | 21712546 | |
424 | Ubiquitination | PSHCLVYKVPSASMS CCCEEEEECCCCCCC | 39.94 | - | |
436 | Ubiquitination | SMSSEEVKQVESGTL CCCHHHHEECCCCCE | 52.48 | - | |
448 | Phosphorylation | GTLRFQFSLGSEEHL CCEEEEEECCCCCCC | 22.49 | 27251275 | |
451 | Phosphorylation | RFQFSLGSEEHLDAP EEEEECCCCCCCCCC | 45.14 | 27050516 | |
459 | Phosphorylation | EEHLDAPTEPVSGPK CCCCCCCCCCCCCCC | 55.42 | 27732954 | |
477 | Phosphorylation | RPSRKPPTSPSSPPA CCCCCCCCCCCCCCC | 62.89 | 30266825 | |
478 | Phosphorylation | PSRKPPTSPSSPPAP CCCCCCCCCCCCCCC | 28.67 | 30266825 | |
480 | Phosphorylation | RKPPTSPSSPPAPVP CCCCCCCCCCCCCCC | 56.07 | 30266825 | |
481 | Phosphorylation | KPPTSPSSPPAPVPR CCCCCCCCCCCCCCC | 37.98 | 30266825 | |
496 | Phosphorylation | VLAAPQNSPVGPGLS EEECCCCCCCCCCCC | 18.73 | 27050516 | |
510 | Phosphorylation | SISQLAASPRSPTQH CHHHHCCCCCCCCCC | 18.42 | 25850435 | |
513 | Phosphorylation | QLAASPRSPTQHCLA HHCCCCCCCCCCCCC | 35.37 | 29743597 | |
621 | Phosphorylation | KQPAEAVSATEPVTF CCCHHHCCCCCCCCC | 36.20 | 28111955 | |
623 | Phosphorylation | PAEAVSATEPVTFNP CHHHCCCCCCCCCCC | 33.06 | 28111955 | |
627 | Phosphorylation | VSATEPVTFNPQKEE CCCCCCCCCCCCCCC | 28.54 | 28111955 | |
731 | Ubiquitination | MVGPGFLKPGERRCF EECCCCCCCCCHHHH | 49.03 | - | |
809 | Ubiquitination | MLGFGRVKPIGVHSV EECCCCCCCCCEEEE | 29.56 | - | |
818 | Ubiquitination | IGVHSVVKGRLHLTL CCEEEEECCEEEEEE | 35.84 | - | |
835 | Ubiquitination | VGHPCEQKVRGCSTL CCCCCCCCCCCCCCC | 16.17 | - | |
847 | Phosphorylation | STLPPSRSRVISNDG CCCCCCCCCEECCCC | 34.93 | 23684312 | |
851 | Phosphorylation | PSRSRVISNDGASRF CCCCCEECCCCCCCC | 26.47 | 23684312 | |
856 | Phosphorylation | VISNDGASRFSGGSL EECCCCCCCCCCCCE | 39.11 | 23684312 | |
859 | Phosphorylation | NDGASRFSGGSLLTT CCCCCCCCCCCEEEC | 40.93 | 23186163 | |
862 | Phosphorylation | ASRFSGGSLLTTGSS CCCCCCCCEEECCCC | 24.59 | 23186163 | |
865 | Phosphorylation | FSGGSLLTTGSSRRK CCCCCEEECCCCCCH | 34.11 | 29978859 | |
866 | Phosphorylation | SGGSLLTTGSSRRKH CCCCEEECCCCCCHH | 34.73 | 29978859 | |
868 | Phosphorylation | GSLLTTGSSRRKHVV CCEEECCCCCCHHHE | 20.69 | 29978859 | |
869 | Phosphorylation | SLLTTGSSRRKHVVQ CEEECCCCCCHHHEE | 37.13 | 29978859 | |
879 | Ubiquitination | KHVVQAQKLADVDSE HHHEEHHHHCCCCHH | 48.97 | - | |
899 | Ubiquitination | LTHARQGKGPQDVSR HHHHHCCCCCCCCCC | 60.11 | - | |
943 | Phosphorylation | TSVLAQQSVRTQHLR HHHHHCCHHHHHHHH | 11.07 | - | |
1027 | Ubiquitination | SQEWRDFKGAAGLHT CHHCCCCCCCCCCCC | 52.51 | - | |
1086 | Ubiquitination | SPGLSNEKGMDAVSP CCCCCCCCCCCCCCC | 64.88 | - | |
1095 | Ubiquitination | MDAVSPWKSSAVPTK CCCCCCCCCCCCCCC | 37.61 | - | |
1142 | Phosphorylation | RFYHPELSFLKKAIR HHHCHHHHHHHHHHC | 27.20 | 24719451 | |
1145 | Ubiquitination | HPELSFLKKAIRLPP CHHHHHHHHHHCCCC | 37.84 | - | |
1146 | Ubiquitination | PELSFLKKAIRLPPW HHHHHHHHHHCCCCC | 51.71 | - | |
1197 | Ubiquitination | EPRDIFLKVASGPSP CCCCEEEEECCCCCH | 25.63 | - | |
1203 | Phosphorylation | LKVASGPSPEIKDFF EEECCCCCHHHCEEE | 38.40 | - | |
1215 | Phosphorylation | DFFVIIYSDRWLATP EEEEEEEECCCCCCC | 15.42 | 27251275 | |
1249 | Phosphorylation | AGQLTRLSLVLRGTQ HHHHHHHHHHHCCCC | 17.09 | 24719451 | |
1272 | Ubiquitination | TSHPQELKTDPKGVF CCCCHHCCCCCCCEE | 50.56 | - | |
1332 | Ubiquitination | CRQPLISKAFEIMLA HCCHHHHHHHHHHHH | 50.53 | - | |
1344 | Ubiquitination | MLAAGEGKGVNKRIT HHHHCCCCCCCCCEE | 56.22 | - | |
1352 | Phosphorylation | GVNKRITYTNPYPSR CCCCCEEECCCCCCC | 11.36 | - | |
1358 | Phosphorylation | TYTNPYPSRRTFHLH EECCCCCCCCEEEEC | 28.66 | - | |
1378 | Phosphorylation | LLRFREDSFQVGGGE HHHEECCCEEECCCC | 16.90 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NPHP4_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NPHP4_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NPHP4_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
606966 | Nephronophthisis 4 (NPHP4) | |||||
Note=Ciliary dysfunction leads to a broad spectrum of disorders, collectively termed ciliopathies. Overlapping clinical features include retinal degeneration, renal cystic disease, skeletal abnormalities, fibrosis of various organ, and a complex range of anatomical and functional defects of the central and peripheral nervous system. The ciliopathy range of diseases includes Meckel-Gruber syndrome, Bardet-Biedl syndrome, Joubert syndrome, nephronophtisis, Senior-Loken syndrome, and Jeune asphyxiating thoracic dystrophy among others. Single-locus allelism is insufficient to explain the variable penetrance and expressivity of such disorders, leading to the suggestion that variations across multiple sites of the ciliary proteome, including NPHP4, influence the clinical outcome. | ||||||
606996 | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...